:

Wendy Meihua Wong1,2, Yvonne Loh3, Hwei Wuen Chan1,2

  • 1Department of Ophthalmology, National University Hospital, National University Health System, Singapore, Singapore.

Frontiers in immunology
|January 22, 2025
PubMed
概括

自主造血干细胞移植 (aHSCT) 为自身免疫视网膜病变 (AIR) 提供了一种潜在的新疗法,该疗法对标准疗法具有抗性. 这种方法使得一个患有胸腺瘤相关的AIR.患者的临床和电生理学改善显著.